메뉴 건너뛰기




Volumn 1, Issue 4, 2011, Pages 130-135

Fibroblast growth factor-23 and Klotho in chronic kidney disease

Author keywords

cardiovascular disease; CKD; FGF 23; hyperparathyroidism; phosphate

Indexed keywords


EID: 84861840749     PISSN: 21571724     EISSN: 21571716     Source Type: Journal    
DOI: 10.1038/kisup.2011.29     Document Type: Review
Times cited : (18)

References (62)
  • 1
    • 0033763097 scopus 로고    scopus 로고
    • Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF-23
    • ADHR Consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF-23. Nat Genet 2000; 26: 345-348.
    • (2000) Nat Genet , vol.26 , pp. 345-348
    • Consortium, A.1
  • 2
    • 14344279878 scopus 로고    scopus 로고
    • Cloning and characterization of FGF-23 as a causative factor of tumor-induced osteomalacia
    • Shimada T, Mizutani S, Muto T et al. Cloning and characterization of FGF-23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A 2001; 98: 6500-6505.
    • (2001) Proc Natl Acad Sci U S A , vol.98 , pp. 6500-6505
    • Shimada, T.1    Mizutani, S.2    Muto, T.3
  • 3
    • 29144500469 scopus 로고    scopus 로고
    • Structural and biochemical properties of fibroblast growth factor
    • Yamashita T. Structural and biochemical properties of fibroblast growth factor Ther Apher Dial 2005; 9: 313-318.
    • (2005) Ther Apher Dial , vol.9 , pp. 313-318
    • Yamashita, T.1
  • 4
    • 0035186837 scopus 로고    scopus 로고
    • Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23
    • White KE, Carn G, Lorenz-Depiereux B et al. Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int 2001; 60: 2079-2086.
    • (2001) Kidney Int , vol.60 , pp. 2079-2086
    • White, K.E.1    Carn, G.2    Lorenz-Depiereux, B.3
  • 5
    • 1642416884 scopus 로고    scopus 로고
    • Targeted ablation of FGF-23 demonstrates an essential physiological role of FGF-23 in phosphate and vitamin D metabolism
    • Shimada T, Kakitani M, Yamazaki Y et al. Targeted ablation of FGF-23 demonstrates an essential physiological role of FGF-23 in phosphate and vitamin D metabolism. J Clin Invest 2004; 113: 561-568.
    • (2004) J Clin Invest , vol.113 , pp. 561-568
    • Shimada, T.1    Kakitani, M.2    Yamazaki, Y.3
  • 6
    • 9244240970 scopus 로고    scopus 로고
    • Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders
    • Bai X, Miao D, Li J et al. Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders. Endocrinology 2004; 145: 5269-5279.
    • (2004) Endocrinology , vol.145 , pp. 5269-5279
    • Bai, X.1    Miao, D.2    Li, J.3
  • 7
    • 3042634460 scopus 로고    scopus 로고
    • Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis
    • Larsson T, Marsell R, Schipani E et al. Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. Endocrinology 2004; 145: 3087-3094.
    • (2004) Endocrinology , vol.145 , pp. 3087-3094
    • Larsson, T.1    Marsell, R.2    Schipani, E.3
  • 8
    • 2142746439 scopus 로고    scopus 로고
    • FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis
    • Shimada T, Hasegawa H, Yamazaki Y et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 2004; 19: 429-435.
    • (2004) J Bone Miner Res , vol.19 , pp. 429-435
    • Shimada, T.1    Hasegawa, H.2    Yamazaki, Y.3
  • 9
    • 35848947037 scopus 로고    scopus 로고
    • Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells
    • Krajisnik T, Bjo rklund P, Marsell R et al. Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 2007; 195: 125-131.
    • (2007) J Endocrinol , vol.195 , pp. 125-131
    • Krajisnik, T.1    Bjo Rklund, P.2    Marsell, R.3
  • 10
    • 36849017126 scopus 로고    scopus 로고
    • The parathyroid is a target organ for FGF-23 in rats
    • Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V et al. The parathyroid is a target organ for FGF-23 in rats. J Clin Invest 2007; 117: 4003-4008.
    • (2007) J Clin Invest , vol.117 , pp. 4003-4008
    • Ben-Dov, I.Z.1    Galitzer, H.2    Lavi-Moshayoff, V.3
  • 11
    • 0141844575 scopus 로고    scopus 로고
    • Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX
    • Liu S, Guo R, Simpson LG et al. Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem 2003; 278: 37419-37426.
    • (2003) J Biol Chem , vol.278 , pp. 37419-37426
    • Liu, S.1    Guo, R.2    Simpson, L.G.3
  • 12
    • 85047691059 scopus 로고    scopus 로고
    • FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting
    • Riminucci M, Collins MT, Fedarko NS et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 2003; 112: 683-692.
    • (2003) J Clin Invest , vol.112 , pp. 683-692
    • Riminucci, M.1    Collins, M.T.2    Fedarko, N.S.3
  • 13
    • 33646367420 scopus 로고    scopus 로고
    • Fibroblast growth factor 23 is a counterregulatory phosphaturic hormone for vitamin D
    • Liu S, Tang W, Zhou J et al. Fibroblast growth factor 23 is a counterregulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol 2006; 17: 1305-1315.
    • (2006) J Am Soc Nephrol , vol.17 , pp. 1305-1315
    • Liu, S.1    Tang, W.2    Zhou, J.3
  • 14
    • 84859832389 scopus 로고    scopus 로고
    • Effects of dietary phosphate and calcium intake on fibroblast growth factor-23
    • Vervloet MG, van Ittersum FJ, Bu ttler RM et al. Effects of dietary phosphate and calcium intake on fibroblast growth factor-23. Clin J Am Soc Nephrol 2010; 6: 83-89.
    • (2010) Clin J Am Soc Nephrol , vol.6 , pp. 83-89
    • Vervloet, M.G.1    Van Ittersum, F.J.2    Bu Ttler, R.M.3
  • 15
    • 15944376583 scopus 로고    scopus 로고
    • Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men
    • Ferrari SL, Bonjour JP, Rizzoli R. Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab 2005; 90: 1519-1524.
    • (2005) J Clin Endocrinol Metab , vol.90 , pp. 1519-1524
    • Ferrari, S.L.1    Bonjour, J.P.2    Rizzoli, R.3
  • 16
    • 33845322655 scopus 로고    scopus 로고
    • Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men
    • Nishida Y, Taketani Y, Yamanuka-Okumura H et al. Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men. Kidney Int 2006; 70: 2141-2147.
    • (2006) Kidney Int , vol.70 , pp. 2141-2147
    • Nishida, Y.1    Taketani, Y.2    Yamanuka-Okumura, H.3
  • 17
    • 79551500014 scopus 로고    scopus 로고
    • Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease
    • Isakova T, Gutierrez OM, Smith K et al. Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease. Nephrol Dial Transplant 2010; 26: 584-591.
    • (2010) Nephrol Dial Transplant , vol.26 , pp. 584-591
    • Isakova, T.1    Gutierrez, O.M.2    Smith, K.3
  • 18
    • 33747719260 scopus 로고    scopus 로고
    • Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men
    • Antoniucci DM, Yamashita T, Portale AA. Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab 2006; 91: 3144-3149.
    • (2006) J Clin Endocrinol Metab , vol.91 , pp. 3144-3149
    • Antoniucci, D.M.1    Yamashita, T.2    Portale, A.A.3
  • 19
    • 20444404265 scopus 로고    scopus 로고
    • Genetic dissection of phosphate-and vitamin D-mediated regulation of circulating FGF-23 concentrations
    • Yu X, Sabbagh Y, Davis SI et al. Genetic dissection of phosphate-and vitamin D-mediated regulation of circulating FGF-23 concentrations. Bone 2005; 36: 971-977.
    • (2005) Bone , vol.36 , pp. 971-977
    • Yu, X.1    Sabbagh, Y.2    Davis, S.I.3
  • 20
    • 33845631059 scopus 로고    scopus 로고
    • Klotho converts canonical FGF receptor into a specific receptor for FGF-23
    • Urakawa I, Yamazaki Y, Shimada T et al. Klotho converts canonical FGF receptor into a specific receptor for FGF-23. Nature 2006; 444: 770-774.
    • (2006) Nature , vol.444 , pp. 770-774
    • Urakawa, I.1    Yamazaki, Y.2    Shimada, T.3
  • 21
    • 0030724491 scopus 로고    scopus 로고
    • Mutation of the mouse klotho gene leads to a syndrome resembling ageing
    • Kuro-o M, Matsumura Y, Yamazaki Y et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997; 390: 45-51.
    • (1997) Nature , vol.390 , pp. 45-51
    • Kuro-O, M.1    Matsumura, Y.2    Yamazaki, Y.3
  • 22
    • 9144248333 scopus 로고    scopus 로고
    • FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa
    • Shimada T, Urakawa I, Yamazaki Y et al. FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa. Biochem Biophys Res Commun 2004; 314: 409-414.
    • (2004) Biochem Biophys Res Commun , vol.314 , pp. 409-414
    • Shimada, T.1    Urakawa, I.2    Yamazaki, Y.3
  • 23
    • 78049481921 scopus 로고    scopus 로고
    • Parathyroid Klotho and FGFreceptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients
    • Krajisnik T, Olauson H, Mirza MA et al. Parathyroid Klotho and FGFreceptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients. Kidney Int 2010; 78: 1024-1032.
    • (2010) Kidney Int , vol.78 , pp. 1024-1032
    • Krajisnik, T.1    Olauson, H.2    Mirza, M.A.3
  • 24
    • 74449094013 scopus 로고    scopus 로고
    • Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease
    • Galitzer H, Ben-Dov IZ, Silver J et al. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease. Kidney Int 2010; 77: 211-218.
    • (2010) Kidney Int , vol.77 , pp. 211-218
    • Galitzer, H.1    Ben-Dov, I.Z.2    Silver, J.3
  • 26
    • 0032489424 scopus 로고    scopus 로고
    • Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein
    • Shiraki-Iida T, Aizawa H, Matsumura Y et al. Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein. FEBS Lett 1998; 424: 6-10.
    • (1998) FEBS Lett , vol.424 , pp. 6-10
    • Shiraki-Iida, T.1    Aizawa, H.2    Matsumura, Y.3
  • 27
    • 34247232767 scopus 로고    scopus 로고
    • Klotho: An antiaging protein involved in mineral and vitamin D metabolism
    • Torres PU, Irie D, Molina-Bletry V et al. Klotho: an antiaging protein involved in mineral and vitamin D metabolism. Kidney Int 2007; 71: 730-737.
    • (2007) Kidney Int , vol.71 , pp. 730-737
    • Torres, P.U.1    Irie, D.2    Molina-Bletry, V.3
  • 28
    • 1642352496 scopus 로고    scopus 로고
    • Klotho is a novel beta-glucuronidase capable of hydrolyzing steroid beta-glucuronides
    • Tohyama O, Imura A, Iwano A et al. Klotho is a novel beta-glucuronidase capable of hydrolyzing steroid beta-glucuronides. J Biol Chem 2004; 279: 9777-9784.
    • (2004) J Biol Chem , vol.279 , pp. 9777-9784
    • Tohyama, O.1    Imura, A.2    Iwano, A.3
  • 29
    • 27144440831 scopus 로고    scopus 로고
    • The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel
    • Chang Q, Hoefs S, van der Kemp AW et al. The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science 2005; 310: 490-493.
    • (2005) Science , vol.310 , pp. 490-493
    • Chang, Q.1    Hoefs, S.2    Van Der Kemp, A.W.3
  • 30
    • 0346849707 scopus 로고    scopus 로고
    • Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system
    • Tsujikawa H, Kurotaki Y, Fujimori T et al. Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol Endocrinol 2003; 17: 2393-2403.
    • (2003) Mol Endocrinol , vol.17 , pp. 2393-2403
    • Tsujikawa, H.1    Kurotaki, Y.2    Fujimori, T.3
  • 31
    • 77956642900 scopus 로고    scopus 로고
    • Klotho: A novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule
    • Hu MC, Shi M, Zhang J et al. Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J 2010; 24: 3438-3450.
    • (2010) FASEB J , vol.24 , pp. 3438-3450
    • Hu, M.C.1    Shi, M.2    Zhang, J.3
  • 32
    • 40149102029 scopus 로고    scopus 로고
    • Klotho as a regulator of oxidative stress and senescence
    • Kuro-o M. Klotho as a regulator of oxidative stress and senescence. Biol Chem 2008; 389: 233-241.
    • (2008) Biol Chem , vol.389 , pp. 233-241
    • Kuro-O, M.1
  • 33
    • 27844561111 scopus 로고    scopus 로고
    • Regulation of oxidative stress by the anti-aging hormone klotho
    • Yamamoto M, Clark JD, Pastor JV et al. Regulation of oxidative stress by the anti-aging hormone klotho. J Biol Chem 2005; 280: 38029-38034.
    • (2005) J Biol Chem , vol.280 , pp. 38029-38034
    • Yamamoto, M.1    Clark, J.D.2    Pastor, J.V.3
  • 34
    • 78650600602 scopus 로고    scopus 로고
    • Klotho is associated with VEGF receptor-2 and the transient receptor potential canonical-1 Ca2+ channel to maintain endothelial integrity
    • Kusaba T, Okigawa M, Matui A et al. Klotho is associated with VEGF receptor-2 and the transient receptor potential canonical-1 Ca2+ channel to maintain endothelial integrity. Proc Natl Acad Sci U S A 2010; 107: 19308-19313.
    • (2010) Proc Natl Acad Sci U S A , vol.107 , pp. 19308-19313
    • Kusaba, T.1    Okigawa, M.2    Matui, A.3
  • 35
    • 0034130405 scopus 로고    scopus 로고
    • Endothelial dysfunction in the klotho mouse and downregulation of klotho gene expression in various animal models of vascular and metabolic diseases
    • Nagai R, Saito Y, Ohyama Y et al. Endothelial dysfunction in the klotho mouse and downregulation of klotho gene expression in various animal models of vascular and metabolic diseases. Cell Mol Life Sci 2000; 57: 738-746.
    • (2000) Cell Mol Life Sci , vol.57 , pp. 738-746
    • Nagai, R.1    Saito, Y.2    Ohyama, Y.3
  • 36
    • 0035986324 scopus 로고    scopus 로고
    • Production of nitric oxide, but not prostacyclin, is reduced in klotho mice
    • Nakamura T, Saito Y, Ohyama Y et al. Production of nitric oxide, but not prostacyclin, is reduced in klotho mice. Jpn J Pharmacol 2002; 89: 149-156.
    • (2002) Jpn J Pharmacol , vol.89 , pp. 149-156
    • Nakamura, T.1    Saito, Y.2    Ohyama, Y.3
  • 37
    • 79953138206 scopus 로고    scopus 로고
    • Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice
    • Doi S, Zou Y, Togao O et al. Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice. J Biol Chem 2011; 286: 8655-8665.
    • (2011) J Biol Chem , vol.286 , pp. 8655-8665
    • Doi, S.1    Zou, Y.2    Togao, O.3
  • 38
    • 2342599742 scopus 로고    scopus 로고
    • Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression
    • Takeshita K, Fujimori T, Kurotaki Y et al. Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression. Circulation 2004; 109: 1776-1782.
    • (2004) Circulation , vol.109 , pp. 1776-1782
    • Takeshita, K.1    Fujimori, T.2    Kurotaki, Y.3
  • 39
    • 79953268951 scopus 로고    scopus 로고
    • Phosphate and klotho
    • Kuro-o M. Phosphate and Klotho. Kidney Int Suppl 2011; 121: S20-S23.
    • (2011) Kidney Int Suppl , vol.121
    • Kuro-O, M.1
  • 40
    • 34548497123 scopus 로고    scopus 로고
    • Fibroblast growth factor 23 (FGF-23) predicts progression of chronic kidney disease: The Mild to Moderate Kidney Disease (MMKD) Study
    • Fliser D, Kollerits B, Never U et al. Fibroblast growth factor 23 (FGF-23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol 2007; 18: 2600-2608.
    • (2007) J Am Soc Nephrol , vol.18 , pp. 2600-2608
    • Fliser, D.1    Kollerits, B.2    Never, U.3
  • 41
    • 79951889923 scopus 로고    scopus 로고
    • FGF-23 as a predictor of renal outcome in diabetic nephropathy
    • Titan SM, Zatz R, Graciolli FG et al. FGF-23 as a predictor of renal outcome in diabetic nephropathy. Clin J Am Soc Nephrol 2010; 6: 241-247.
    • (2010) Clin J Am Soc Nephrol , vol.6 , pp. 241-247
    • Titan, S.M.1    Zatz, R.2    Graciolli, F.G.3
  • 43
    • 49249104701 scopus 로고    scopus 로고
    • Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
    • Gutierrez OM, Mannstadt M, Isakova T et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008; 359: 584-592.
    • (2008) N Engl J Med , vol.359 , pp. 584-592
    • Gutierrez, O.M.1    Mannstadt, M.2    Isakova, T.3
  • 44
    • 67650892239 scopus 로고    scopus 로고
    • Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community
    • Mirza MA, Larsson A, Lind L et al. Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community. Atherosclerosis 2009; 205: 385-390.
    • (2009) Atherosclerosis , vol.205 , pp. 385-390
    • Mirza, M.A.1    Larsson, A.2    Lind, L.3
  • 45
    • 70349656941 scopus 로고    scopus 로고
    • Relationship between circulating FGF-23 and total body atherosclerosis in the community
    • Mirza MA, Hansen T, Johansson L et al. Relationship between circulating FGF-23 and total body atherosclerosis in the community. Nephrol Dial Transplant 2009; 24: 3125-3131.
    • (2009) Nephrol Dial Transplant , vol.24 , pp. 3125-3131
    • Mirza, M.A.1    Hansen, T.2    Johansson, L.3
  • 46
    • 70450230670 scopus 로고    scopus 로고
    • Serum intact FGF-23 associate with left ventricular mass, hypertrophy and geometry in an elderly population
    • Mirza MA, Larsson A, Melhus H et al. Serum intact FGF-23 associate with left ventricular mass, hypertrophy and geometry in an elderly population. Atherosclerosis 2009; 207: 546-551.
    • (2009) Atherosclerosis , vol.207 , pp. 546-551
    • Mirza, M.A.1    Larsson, A.2    Melhus, H.3
  • 47
    • 79953046736 scopus 로고    scopus 로고
    • Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men
    • Mirza MA, Karlsson MK, Mellstrom D et al. Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men. J Bone Miner Res 2011; 26: 857-864.
    • (2011) J Bone Miner Res , vol.26 , pp. 857-864
    • Mirza, M.A.1    Karlsson, M.K.2    Mellstrom, D.3
  • 48
    • 77956884451 scopus 로고    scopus 로고
    • FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease
    • Yilmaz MI, Sonmez A, Saglam M et al. FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease. Kidney Int 2010; 78: 679-685.
    • (2010) Kidney Int , vol.78 , pp. 679-685
    • Yilmaz, M.I.1    Sonmez, A.2    Saglam, M.3
  • 50
    • 79953880208 scopus 로고    scopus 로고
    • Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients
    • Kirkpantur A, Balci M, Gurbuz CA et al. Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients. Nephrol Dial Transplant 2011; 26: 1346-1354.
    • (2011) Nephrol Dial Transplant , vol.26 , pp. 1346-1354
    • Kirkpantur, A.1    Balci, M.2    Gurbuz, C.A.3
  • 51
    • 77958565641 scopus 로고    scopus 로고
    • Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease
    • Kanbay M, Nicoleta M, Selcoki Y et al. Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease. Clin J Am Soc Nephrol 2010; 5: 1780-1786.
    • (2010) Clin J Am Soc Nephrol , vol.5 , pp. 1780-1786
    • Kanbay, M.1    Nicoleta, M.2    Selcoki, Y.3
  • 52
    • 4444308167 scopus 로고    scopus 로고
    • Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism
    • Sato T, Tominaga Y, Ueki T et al. Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism. Am J Kidney Dis 2004; 44: 481-487.
    • (2004) Am J Kidney Dis , vol.44 , pp. 481-487
    • Sato, T.1    Tominaga, Y.2    Ueki, T.3
  • 53
    • 77957993384 scopus 로고    scopus 로고
    • PTH increases FGF-23 gene expression and mediates the high-FGF-23 levels of experimental kidney failure: A bone parathyroid feedback loop
    • Lavi-Moshayoff V, Wasserman G, Meir T et al. PTH increases FGF-23 gene expression and mediates the high-FGF-23 levels of experimental kidney failure: a bone parathyroid feedback loop. Am J Physiol Renal Physiol 2010; 299: F882-F889.
    • (2010) Am J Physiol Renal Physiol , vol.299
    • Lavi-Moshayoff, V.1    Wasserman, G.2    Meir, T.3
  • 54
    • 31544450766 scopus 로고    scopus 로고
    • Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF-23 in renal failure rats
    • Nagano N, Miyata S, Abe M et al. Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF-23 in renal failure rats. Kidney Int 2006; 69: 531-537.
    • (2006) Kidney Int , vol.69 , pp. 531-537
    • Nagano, N.1    Miyata, S.2    Abe, M.3
  • 55
    • 77749334660 scopus 로고    scopus 로고
    • Early control of PTH and FGF-23 in normophosphatemic CKD patients: A new target in CKD-MBD therapy
    • Oliveira RB, Cancela AL, Graciolli FG et al. Early control of PTH and FGF-23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy? Clin J Am Soc Nephrol 2010; 5: 286-291.
    • (2010) Clin J Am Soc Nephrol , vol.5 , pp. 286-291
    • Oliveira, R.B.1    Cancela, A.L.2    Graciolli, F.G.3
  • 56
    • 77955110868 scopus 로고    scopus 로고
    • Fibroblast growth factor 23 in hemodialysis patients: Effects of phosphate binder, calcitriol and calcium concentration in the dialysate
    • Cancela AL, Oliveira RB, Graciolli FG et al. Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate. Nephron Clin Pract 2011; 117: c74-c82.
    • (2011) Nephron Clin Pract , vol.117
    • Cancela, A.L.1    Oliveira, R.B.2    Graciolli, F.G.3
  • 57
    • 79961052017 scopus 로고    scopus 로고
    • Lanthanum carbonate reduces FGF23 in chronic kidney disease stage 3 patients
    • Gonzalez-Parra E, Gonzalez-Casaus ML, Galan A et al. Lanthanum carbonate reduces FGF23 in chronic kidney disease stage 3 patients. Nephrol Dial Transplant 2011; 26: 2567-2571.
    • (2011) Nephrol Dial Transplant , vol.26 , pp. 2567-2571
    • Gonzalez-Parra, E.1    Gonzalez-Casaus, M.L.2    Galan, A.3
  • 58
    • 60749130276 scopus 로고    scopus 로고
    • Mortality reduction by vitamin D receptor activation in end-stage renal disease: A commentary on the robustness of current data
    • Vervloet MG, Twisk JW. Mortality reduction by vitamin D receptor activation in end-stage renal disease: a commentary on the robustness of current data. Nephrol Dial Transplant 2009; 24: 703-706.
    • (2009) Nephrol Dial Transplant , vol.24 , pp. 703-706
    • Vervloet, M.G.1    Twisk, J.W.2
  • 59
    • 77951726222 scopus 로고    scopus 로고
    • Fibroblast growth factor (FGF)-23 and fetuin-A in calcified carotid atheroma
    • Voigt M, Fischer DC, Rimpau M et al. Fibroblast growth factor (FGF)-23 and fetuin-A in calcified carotid atheroma. Histopathology 2010; 56: 775-788.
    • (2010) Histopathology , vol.56 , pp. 775-788
    • Voigt, M.1    Fischer, D.C.2    Rimpau, M.3
  • 60
    • 65649103814 scopus 로고    scopus 로고
    • Initial FGF-23-mediated signaling occurs in the distal convoluted tubule
    • Farrow EG, Davis SI, Summers LJ et al. Initial FGF-23-mediated signaling occurs in the distal convoluted tubule. J Am Soc Nephrol 2009; 20: 955-960.
    • (2009) J Am Soc Nephrol , vol.20 , pp. 955-960
    • Farrow, E.G.1    Davis, S.I.2    Summers, L.J.3
  • 61
    • 84859753990 scopus 로고    scopus 로고
    • Development of Klotho-FGFR1/3 dependent resistance to FGF-23 in human aortic smooth muscle cells exposed to calcifying stress
    • Lim K, Lu TS, Zehnder D et al. Development of Klotho-FGFR1/3 dependent resistance to FGF-23 in human aortic smooth muscle cells exposed to calcifying stress. J Am Soc Nephrol 2010; 21: 140A.
    • (2010) J Am Soc Nephrol , vol.21
    • Lim, K.1    Lu, T.S.2    Zehnder, D.3
  • 62
    • 78651408919 scopus 로고    scopus 로고
    • Klotho deficiency causes vascular calcification in chronic kidney disease
    • Hu MC, Shi M, Zhang J et al. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 2011; 22: 124-136.
    • (2011) J Am Soc Nephrol , vol.22 , pp. 124-136
    • Hu, M.C.1    Shi, M.2    Zhang, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.